DASH Pharmaceuticals LLC: Drug Recall
Recall #D-0749-2022 · 03/11/2022
Class II: Risk
Recall Details
- Recall Number
- D-0749-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- DASH Pharmaceuticals LLC
- Status
- Terminated
- Date Initiated
- 03/11/2022
- Location
- Upper Saddle River, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 45,940 Unit Dose Cups
Reason for Recall
Labeling: Label Mix-Up
Product Description
Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) and b) 100 case of 10 mL Unit Dose Cups (NDC 69339-148-19) Rx Only, Dash Pharmaceuticals, Upper Saddle River, NJ 07458.
Distribution Pattern
Nationwide within the United States
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.